PaFLO: Pazopanib with 5-fluorouracil, leucovorin, and oxaliplatin (FLO) as first-line treatment in advanced gastric cancer: A randomized phase II study of theĀ Arbeitsgemeinschaft internistische Onkologie (AIO).
Kirstin Breithaupt
No relevant relationships to disclose
Dmitry Bichev
No relevant relationships to disclose
Mario Lorenz
No relevant relationships to disclose
Daniela Bohnen
No relevant relationships to disclose
Yasemin Dogan
No relevant relationships to disclose
Peter Schlattmann
No relevant relationships to disclose
Salah-Eddin Al-Batran
No relevant relationships to disclose
Markus Hermann Moehler
No relevant relationships to disclose
Peter C. Thuss-Patience
Research Funding - GlaxoSmithKline